definiens: shall mean:(i)the Patents that Cover the development, manufacture, use, or commercialization of theProducts, including those Patents identified in Part 1 and Part 2 of Schedule 1 ( the);(ii)the Know - How that is necessary or reasonably useful for the research, development, use, offering for sale, sale, import, and export of Products, but excluding Know - How forthe Manufacture of Products ( which is described in Clause 1.1(k)(iii ) ( BioMedica IP ) ) ; and(iii)the Know - How that is reasonably useful ( that exists as of the date of transfer pursuant toClause 7.3 ( Technology Transfer ) ) or that is necessary ( that exists at any time during theTerm ) to practice the process transferred to the Licensee or its designee pursuant toClause 7.3 ( Technology Transfer ) for Manufacture of Products;(together 1.1(k)(ii ) ( BioMedica IP ) and 1.1(k)(iii ) ( BioMedica IP ) being the ) ; in each case, to the extent Controlled by BioMedica as of the Effective Date or during the Term, but excluding the BioMedica TRiP Patents and BioMedica TRiP Know - How ( subject to Clause2.2(a ) ( TRiP and WPRE Option ) ) and the WPRE Patent ( subject to Clause 2.2(a ) ( TRiP andWPRE Option ) )